Agendia

Agendia is a genomic diagnostics company in Irvine, CA, focused on early-stage breast cancer, offering the MammaPrint recurrence-risk test and BluePrint molecular subtyping test to help clinicians match patients to treatment. It also has a European base in Amsterdam, and its tests are used in more than 45 countries.